STOCK TITAN
  1. Home
  2. News
  3. EBS

Emergent Biosolutions Inc - EBS STOCK NEWS

IMPACT
SENTIMENT
EBS : NYSE
Emergent BioSolutions to Release Third Quarter 2023 Financial Results and Conduct Conference Call on November 2, 2023
acquisition earnings
IMPACT
SENTIMENT
EBS : NYSE
Emergent BioSolutions Partners with Emmitt Smith to Launch Ready to Rescue Campaign to Help Save Lives Amidst Rising Opioid Epidemic
partnership acquisition
IMPACT
SENTIMENT
EBS : NYSE
Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors
management acquisition
IMPACT
SENTIMENT
EBS : NYSE
Emergent BioSolutions’ NARCAN® Nasal Spray Launches Over the Counter Making it Possible for Everyone to Help Save a Life from an Opioid Overdose Emergency
acquisition
IMPACT
SENTIMENT
EBS : NYSE
Emergent BioSolutions Reports Financial Results for Second Quarter 2023
acquisition earnings
IMPACT
SENTIMENT
EBS : NYSE
Emergent BioSolutions Announces Strategic Steps to Strengthen Core Business and Financial Position
acquisition
IMPACT
SENTIMENT
EBS : NYSE
Emergent BioSolutions Awarded 10-Year BARDA Contract Valued at up to a Maximum of $704 Million for Advanced Development and Procurement of Ebanga™ Treatment for Ebola
acquisition
IMPACT
SENTIMENT
EBS : NYSE
Emergent BioSolutions to Release Second Quarter 2023 Financial Results and Conduct Conference Call on August 8, 2023
acquisition earnings
IMPACT
SENTIMENT
EBS : NYSE
Emergent BioSolutions Receives U.S. FDA Approval of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted), previously known as AV7909, a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use
acquisition fda approval
IMPACT
SENTIMENT
EBS : NYSE
Emergent BioSolutions Announces CEO Transition
acquisition
Stock EBS logo
Emergent Biosolutions Inc
NYSE:EBS

EBS Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link

About EBS

emergent biosolutions is a global life sciences company dedicated to one simple mission—to protect and enhance life. we develop, manufacture, and deliver a portfolio of medical countermeasures for biological and chemical threats as well as emerging infectious diseases. through our work, we envision protecting and enhancing 50 million lives with our products by 2025. additional information about the company may be found at www.emergentbiosolutions.com. follow us @emergentbiosolu and @life_at_emergent